Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.
from Reuters: Health News https://reut.rs/2IQcxFd
Tuesday, April 30, 2019
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment